Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03430674 · ClinicalTrials.gov registry record · NA

Evaluation of an Exercise Intervention for Vincristine Induced Peripheral Neuropathy in Pediatric Cancer Patients

A NA study, sponsored by Indiana University.

Completed
Registry status
NA
Development phase
10
Enrollment target

NCT03430674 is a NA study that has completed, run by Indiana University. The registered enrollment target is 10 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03430674, a NA study, has completed, sponsored by Indiana University.

COMPLETED
Registry status
NA
Development phase
10 participants
Enrollment target

Study Summary

The purpose of this study is to better understand whether or not children with ALL can complete an exercise program during treatment and whether or not that program may impact peripheral neuropathy. Researchers will also study changes in the blood and body that may occur during the program by collecting samples of blood at various times during the study. Aim 1: Evaluate the feasibility and acceptability of EX as an intervention for VIPN in pediatric patients with ALL. Aim 2: Estimate preliminary effect sizes of the EX intervention.

Interventions

  • BEHAVIORAL Exercise

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2018-07-01
Est. Completion 2019-10-30
Phase NA

Sponsor

Indiana University

890 total trials

What the Registry Record Tells You About NCT03430674

The ClinicalTrials.gov registry entry for NCT03430674 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Exercise is the first listed.

NCT03430674 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03430674 about?

NCT03430674 is a clinical study titled "Evaluation of an Exercise Intervention for Vincristine Induced Peripheral Neuropathy in Pediatric Cancer Patients". The purpose of this study is to better understand whether or not children with ALL can complete an exercise program during treatment and whether or not that program may impact peripheral neuropathy. Researchers will also study changes in the blood and body that may occur during the program by collec...

What is the current status of trial NCT03430674?

This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2018-07-01. Estimated completion is 2019-10-30.

What interventions are being tested in trial NCT03430674?

The interventions under investigation include: Exercise (BEHAVIORAL).

Who is sponsoring clinical trial NCT03430674?

This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.